• M.D., University of Texas Medical Branch, Galveston
• B.A., Yale University

• Published over 400 articles
• James Isaacson Research Award from the International Society

• M.B.A., Mount St. Mary's University 
• B.S., Southern Illinois University

• Deputy Executive Officer, NIAAA 
• Deputy Executive Officer, NEI 
• Director, Officer of Intramural Research Administration, NIMH  
• Chief, Intramural Administrative Services Branch, NIMH

• 25 years of administrative and management experience at NIH 
• Recipient of NIH Directors Award for efforts co-leading the NIH Optimize Travel working group 
• Appointed to Senior Executive Service in August, 2016 
• Graduate of NIH Senior Leadership Program 
• Member of the NIH Federal Credit Union Board of Directors

• M.D., Thomas Jefferson University, Philadelphia  
• M.P.H., University of Washington, Seattle  
• B.S., Harvard University

•  Director, Division of Infectious Diseases at the University of Alabama at Birmingham

• Oversees NIAID’s extensive portfolio of research to advance understanding, diagnosis, and treatment of infectious, immunologic, and allergic diseases. 
• Leads strategic planning for NIAID’s ability to respond to urgent and emerging infectious diseases.
• Has led transformational research into understanding the role of the vaginal microbiome in sexual and reproductive health.
• Recipient of the American Sexually Transmitted Disease Association Lifetime Career Achievement Award for research in the prevention, management, and diagnosis of STDs.

• M.D., Georgetown University, Washington, D.C. 
• M.H.S. Duke University, Durham, N.C 
• B.A. Georgetown University, Washington, D.C.

• Deputy Director, NIAID/Division of AIDS

• Oversees NIAID’s extensive portfolio of research to advance understanding, diagnosis, and treatment of infectious, immunologic, and allergic diseases.
• Leads strategic planning for NIAID’s ability to respond to urgent and emerging infectious diseases. 
• Had managed the Division of AIDS more than $1 billion HIV/AIDS research portfolio and clinical trials networks and played a major role in advancing science for the prevention and treatment of HIV/AIDS, co-infections such as tuberculosis, and non-infectious complications of HIV, such as cardiovascular disease among people with HIV.  
• Played a major role in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership, a component of NIH’s response to the COVID-19 pandemic.  

• M.D., Johns Hopkins University School of Medicine
• B.A., St. John’s College

• Research areas of special interest have included chronic Granulomatous disease, Job's syndrome (autosomal dominant STAT3 deficiency) and the genetic conditions predisposing people to mycobacterial infections. More recently, he has been interested in genetic conditions associated with severe coccidioidomycosis and acquired forms of anticytokine autoimmunity predisposing to opportunistic infections.
• Recipient of many awards, including American College of Physicians Award for Science, the Boyle Scientific Achievement Award of the Immune Deficiency Foundation, and the American Society for Microbiology Abbott Award.

• M.D., Indiana University School of Medicine
• M.P.H., Johns Hopkins University School of Public Health
• M.S., Cornell University

• Responsible for the strategic and scientific vision for the NIAID Division of Microbiology and Infectious Diseases (DMID) complex national and international research program.  DMID supports basic, preclinical, and clinical investigations into the causes, diagnosis, treatment, and prevention of a broad range of pathogens, including those related to biodefense and emerging infectious diseases.
• Develops and manages strategic collaborative relationships with outside partners focused on advancing DMID’s scientific mission. These partnerships include but are not limited to other NIH institutes and centers, BARDA, CDC, CEPI, and WHO.

• M.D., Boston University School of Medicine

• Developed transformative approaches to data transparency and public access.
• Co-chaired the Immunity and Inflammation Steering Committee of the Foundation for NIH Biomarkers Consortium.
• Provides scientific leadership and programmatic direction for the Division of Allergy, Immunology, and Transplantation extramural research portfolio.

• M.D., University of Michigan
• B.S., University of Michigan

• Pioneered the strategies of immunologically compatible bone marrow transplantation and the adoptive transfer of lymphocytes and has examined the roles of cytokines in treating patients with HIV infection.
• Served in the U.S. Public Health Service Commissioned Corps from 1979 to 2008 where he achieved the rank of Rear Admiral and served as Assistant Surgeon General.
• NIAID liaison with the U.S. Departments of Defense and Homeland Security.
• One of the first investigators to study immunopathogenic mechanisms of HIV disease, ultimately making seminal observations that helped establish the field of HIV immunopathogenesis.

• Masters of Art in Economics 
• The George Washington University

• Budget Officer, NIAAA

• Responsible for the formulation, justification, presentation and execution of annual, reimbursable and multi-year budget appropriation of NIAID totaling $8 Billion.

• Ph.D., Johns Hopkins University
• B.S., University of Maryland

• Played a key role in restructuring the DAIDS-supported clinical trials research networks.
• Actively fostered collaboration and partnerships with other federal agencies, international research organizations, professional societies, foundations, community advocacy groups, and industry.
• Oversees a global HIV/AIDS research portfolio of more than $1 billion and a staff of more than 150 federal employees.

BS, Oglethorpe University

MA, Princeton University

PhD, Princeton University

Associate Director for Science Management, NIAID

Director, Office of Biodefense Research and Surety

• M.D., University of California, San Francisco (UCSF)
• D.Sc., (genetic epidemiology) Netherlands Institute for Health Sciences, Rotterdam
• B.A. (genetics) and M.P.H. (epidemiology), University of California, Berkeley

• Vice Chancellor of Research, UCSF
• Professor of Rheumatology and Chief of the Division of Rheumatology, UCSF
• Professor of Orofacial Sciences, UCSF
• Co-Program Director, Clinical & Translational Sciences Institute, UCSF

• Made seminal discoveries in genetic epidemiology of autoimmune rheumatic disease, including systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome
• Contributed to the identification of more than 30 genes linked to these disorders
• Authored/co-authored more than 250 research papers
• Invited speaker at many international and national scientific meetings
• Elected to the Association of American Physicians, an honor extended to physicians with outstanding credentials in biomedical research
• Recipient of numerous awards while at UCSF, including the Kenneth H. Fye, M.D., endowed chair in rheumatology, the Jean S. Engleman distinguished professorship in rheumatology, and the 2014 Resident Clinical and Translational Research Mentor of the Year. Nominated three times for the Chancellor’s Award for the Advancement of Women. Received the Henry Kunkel Young Investigator Award from the American College of Rheumatology

• M.D., Harvard University
• B.S., Williams College

• Member of the Association of American Physicians, the American College of Rheumatology (ACR), the American Association of Immunologist. Served on the Committee for Research of the ACR, and the Medical and Scientific Advisory Committee for the Lupus Foundation of America, Inc.
• Lead multiple initiatives at the NIAMS and the NIH, including Chair of the NIAMS Centers Evaluation Working Group and co-Chair of the Accelerating Medicines Partnership in rheumatoid arthritis and in lupus.

• M.D., University of Cincinnati
• B.S., St. Lawrence University

• Received the U.S. Public Health Service Physician Researcher of the Year Award, the Paul Bunn Award in Infectious Disease, the Lee C. Howley Prize in Arthritis Research and the Irish Society for Immunology Public Lecture Award.
• Ross Prize in Molecular Medicine Award 2014
• Elected to Institute of Medicine 2015
• The David W. Talmage Lectureship Award 2015
• Nobel Forum Lecture, Stockholm, Sweden 2015
• National Jewish Hospital Distinguished Lecturer 2016
• AAI Distinguished Lecturer 2016
• Society for Investigative Dermatology – Stone Lectureship 2016
• Also received the NIAMS Mentoring Award in 2003 and the NIH “Make a Difference” Office of Equal Opportunity Award in 2006

• M.D., Ph.D., University of Rochester School of Medicine and Dentistry
• B.A. Boston University

• Director, Division of Rheumatology, Cincinnati Children's Hospital Medical Center

• Member of the American College of Rheumatology (ACR) and American Association of Immunologists (AAI).
• Chaired ACR Committee on Research and served on the Board of Directors.
• Serves on Medical and Scientific Advisory Board of the Spondylitis Association of America.